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Background: Cancer is an important cause of mortality in many of the economically 
developed nations of the world. More than 10% of all deaths in children below 15 years of 
age are caused by malignant diseases in developed countries. In the developing world, 
childhood cancers are yet to be recognized as a major pediatric illness due to several other 
competing causes of death like diarrheal illness and respiratory illness. 
 Methods: A descriptive retrospective study of children admitted for cancer in Butare 
Teaching Hospital over a 7 years period (January 1999-December 2005) was carried out 
The study population included 36 children aged 0-15 years admitted with cancer at Butare 
university teaching Hospital. Data was analyzed using Epi data, SPSS11,5  computer 
programs. 
Results: The average age of our patients was 5.9 years with the youngest patient being 5 
month old. The peak incidence of cancer was found in the 0-5 years age group and 
accounted for 21 patients (58, 3%). The Male to Female sex ratio was 1.7: 1. The most 
common types of cancer were: Burkett’s lymphoma, Non-Hodgkin Lymphoma and 
Hodgkin’s Lymphoma. Treatment included   surgery for 17 patients(47.2%), 
chemotherapy for 4 patients (11.1%),  surgery  combined  with  post-operative  
chemotherapy for 1 patient (2.7%), the  association  of  pre-operative  chemotherapy + 
surgery + post-operative  chemotherapy  for 1 patient (2.7%)  and  palliative care for 13 
patients (36.1%).  The average length of hospital stay was 36.6 days ranging   from 2 to 510   
days. The hospital mortality rate was 27.7%.  
Recommendation: The creation of an oncology department and a National cancer Register 
are recommended. 
• Presented at Association of Surgeons of East Africa Conference in Mombasa, Kenya- Dec 6, 
2007. 
Introduction                                                          
Although, Cancer is rare in children aged 
less than 15 years1, it represents a main 
concern for parents, families, and health 
professionals to care for children affected 
with cancer. The problems confronting 
Paediatric oncology in Africa are many. 
They are linked to: 
• Lack of common strategy and 
policies concerning detection, 
prevention, and treatment of cancer 
patients 
• Insufficient specialized human 
resources, 
• Absence of referral cancer centers, 
• Unavailability of antimitotic drugs 
and radiotherapy, 
• Lack of financial resources 
• Patients consulting at late stage of 
cancer. 
These lead to low survival and cure rates: 
The patients’ survival at 5 years is ≤ 50% in 
developing world whereas cure rates in 
developed countries represent 75-80 %1. In 
Rwanda there is no possibility of effective, 
efficient management of cancer after 
diagnosis is confirmed for lack of an 
established oncology Department. A review 
of literature shows that no specific study on 
cancer in children has bee reported from 
Rwanda. It was with such background that a 
study was undertaken on childhood cancers 




During 7 years period of our study, there 
were 20,171 admitted patients in the five 
departments of Paediatric, Surgery, ENT, 
Ophthalmology and Stomatology of whom 
36 (0.18%) patients had childhood cancer. 
Table 1 shows the annual distribution of 
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children with cancer in the 7 years. Figure 1 
shows the age distribution. The age group 0 
to 5 years was the most affected accounting 
for 21 (58.3%) of the cases. The youngest 
patient was aged 5 months (Figure 1). 
Twenty three patients were males and 13 
were females. (Male: female ratio = 1.8: 1). 
Table 2 shows the distribution of cancers 
according to age groups. The 0 – 5 year age 
group accounted for 21 (58.3%) of the 
cases. The commonest malignancy in this 
age group was Burkitt’s lymphoma. 
Burkitt‘s Lymphomas were accounted for a 
third (33.3%) of the tumours in the 0 – 5 age 
group (Table 2). The commonest type in the 
6 – 10 years age group was non Hodgkin’s 
lymphoma. In males, Burkitt’s lymphoma 
accounted for 14 (60.9%) of cancers while 
in females the tumours were more evenly 
distributed (Table 3). Table 4 shows the 
location of the cancers. Most tumours were 
located in accessible sites for the guardians 
or patients as well as the health workers.  
 
Clinical features on the 5 main cancers were 
many. A swelling or mass was the 
predominant presentation. Other features 
included pyrexia, peripheral 
lymphadenopathy, hepatomegaly, 
splenomegaly, weight loss, pallor and 
abdominal tenderness. Others signs and 
symptoms deferred  from one type of cancer 
to the other. The site of tumour varied. 
Burkitt’s lymphoma was located in maxilla 
and mandible (8 cases over 10:80%). Thirty 
four patients had confirmed histological 
diagnosis. Two patients had diagnosis 
confirmed by bone marrow examination. 
 
Tables 6 and 7 summarize the mode of 
treatment received by the children. One 
form of surgery or the other was performed 
in 17 (47.2%) of the patients and included 
tumour excision, limb amputation, 
Nephrectomy, eye exenteration and others. 
Only 4 patients (11.1%) benefited from 
chemotherapy. Palliative treatment was 
offered to 13 patients with advanced 
disease. Palliative care included analgesics, 
intravenous fluids, blood transfusion, and 
nursing. Radiotherapy is not offered in 
Rwanda and therefore none of the patients 
had such a modality of treatment. Only 4 
patients had chemotherapy. Two patients 
with NHML received a combination of 
Endoxan 40mg /m2 + Vincristine + 
Methotrexate + Prednisolone for 2 sessions.  
One patient with Burkitt’s 
Lymphomareceived 3 sessions of Endoxan 
40mg/m2 and Prednisolone 2mg/ kg. One 
patient with Acute Lymphoïd  Leukemia 
had Endoxan 40mg/m2 + 
Vincristine1,5mg/m2 + L-Asparaginase+ 
Methotrexate + Prednisolone 2 mg/kg. 
 
The average length of stay in hospital was 
36.6% days with the extremes of 2 days and 
510 days.  
 
Table 1. Patients’ Distribution According to Years of Admission.  
 
Department Year  
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Table 2.  Age Distribution and type of cancer.   
 
Age group (years) 
Type  of cancer 
0 to 5 6 to 10 11 to 15 
Total 
*NHL  0 6 1 7 
Burkitt’s Lymphoma  7 3 0 10 
Hodgkin’s Lymphoma 2 0 2 4 
Retinoblastoma 2 0 0 2 
Rhabdomyosarcoma 2 0 0 2 
Nephroblastoma 2 0 0 2 
Neuroblastoma 1 0 0 1 
Osteosarcoma 0 0 1 1 
Non-specified Sarcoma 1 0 0 1 
Malignant Schwanoma  1 0 0 1 
Hepatoblastoma 1 0 0 1 
Malignant Mélanoma 0 1 0 1 
**AcLL  2 0 1 3 
Total 21 10 5 36 
*NHL = Non Hodgkin Lymphoma,    **Ac LL = Acute Lymphoïd Leukemia 
 
  
Table 3. Patient Distribution According to Type of Cancer and Sex. 
 
Sex Type of cancer 
Male Female 
Total M :F Sex Ratio 
*NHL  6 1 7 6 :1 
Burkitt’Lymphoma 8 2 10 4 :1 
Hodgkin’sLymphoma 3 1 4 3 :1  
Retinoblastoma 0 2 2 0 :2 
Rhabdomyosarcoma 1 1 2 1 :1 
Nephroblastoma 1 1 2 1 :1 
Neuroblastoma 1 0 1 1 :0 
Osteosarcoma 0 1 1 0 :1 
Non-specified Sarcoma 0 1 1 0 :1 
Malignant Schwanoma 0 1 1 0 :1 
Hepatoblastoma 0 1 1 0 :1 
Malignant Melanoma 1 0 1 1 :0 
**Ac LL  2 1 3 2 :1 
Total 23 13 36 1.8 :1 
 
*NHL = Non Hodgkin Lymphoma,    **Ac LL = Acute Lymphocytic Leukemia 
 
Patients’ complications were: infection, 
bonemarrow aplasia, blindness, nausea, 
vomiting,  observed in 4 (27.7%) patients 
who had Burkiitt’s Lymphoma, acute 
leukemia or Hodgkin lymphoma under 
chemotherapy. 
 
The outcome at discharge varied: 11 
patients (30.5%) improved, 15 patients 
(41.6%) didn’t improve that is general state 
remained the same or worsened. Ten 
patients died in hospital (27.8% mortality)  
 
and included 1 patient who had surgery, all 
4 patients treated with chemotherapy  and 5 
patients managed with palliative care alone.  
The patients’ follow up was difficult, only 3 
patients over 36 was seen 1 month later. 
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0 - 5 years 6- 10 years 11-15 years
     
Figure1.  Group age distribution 
 
Table 4. Sites of Cancers.  
 
Type of cancer 
 
Site  of  Tumour Number  
Retro-auricular 1 
Abdominal (right kidney) 1 




Supra maxillar 2 
Right tibia 1 
Cervical nodes 2 




Hodgkin’ Lymphoma Neck lymphonodes 4/4 
Cervical  1 
bladder   1 
Rhabdomyosarcoma 
Total 2 
Nephroblastoma Right kidney 2/2 
Right eye 1 
Left   eye 1 
Retinoblastoma 
Total 2 
Table 5. Histological Types of Cancer in Children 
 
 





NHL 7 19.4 
Burkitt’s Lymphoma 10 27.7 
Hodgkin’s Lymphoma 4 11.1 
Retinoblastoma 2 5.5 
Rhabdomyosarcoma 2 5.5 
Nephroblastoma 2 5.5 
Neuroblastoma 1 2.7 
Osteosarcoma 1 2.7 
Non identified Sarcoma 1 2.7 
Malignant Schwanoma 1 2.7 
Hepatoblastoma 1 2.7 
Malignant Melanoma 1 2.7 
Acute Lymphoid Leukemia 3 8.3 
Total 36 100 
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Tumor excision 12 33.3 
Limb amputation  1 2.7 
Nephrectomy  2 5 .5 
Surgery 




Cyclophosphamide+Prednisolone 1 2.7 
Chemotherapy 
Cyclophοsphamide + Vincristine+L-Asparaginase + 




Limb amputation+Cyclophοsphamide+ Vincristine + 




Analgesics, ATB, intravenous fluids, blood  transfusion, 





Cyclophosphamide + Vincristine+Prednisolone + 
Nephrectomy+ Cyclophosphamide + Vincristine + 










Tableau 7. Patients  outcome versus type of cancer 
 
Total Type of cancer 
Improved No Improvement Died in hospital Total  
*NHL 2 3 2 7 
Burkitt’s Lymphoma 1 7 2 10 
**HL 1 2 1 4 
Acute leukemia 0 0 3 3 
Retinoblastoma 2 0 0 2 
Rhabdomyosarcoma 0 1 1 2 
Nephroblastoma 2 0 0 2 
Others  3 2 1 6 















Cancer is a subject of constant 
preoccupation in the world1. It is rare in 
children aged less than 15 years, it 
represents 1-3% of all tumors in the 
population2,3,4,5,6,7. In France, each year 1800 
to 2000 new cases of cancer in children are 
registered1,3,8. In Switzerland, 220 children; 
in Belgium less than 300 children are 
affected each year. This study confirmed 
that cancer in children is a rare . Our 
hospital prevalence was similar to that 
reported by other sauthors3,5,6,9. The disease 
predominantly affects young children in the 
0 -5 years age group. Other studies have 
reported similar findings.1,2,6.  
 
The clinical presentation in our children  
was in agreement with previous 
literature10,3,7,11,12. The patients’ 
management and outcome in our series 
significantly differed from what is reported 
by other centres with established surgical 
oncology departments1,3,5,13. In our study, 
surgical treatment, being the only available 
form of treatment for cancer in the country, 
was offered to many cases.. Antimitotics 
drugs were not always available, and they 
were too expensive for  ordinary Rwandese 
patients. There is no Radiotherapy Centre in 
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the country nor is there any well established 
chemotherapy unit. This unfortunate 
situation contributed to the poor outcome 
and bad prognosis of our patients. The need 
for establishing such centres in the country 
is overwhelming. 
Conclusion 
Our findings showed that the clinical features 
and pathological types of cancersseen among 
children in Rwanda were similar to what has 
been reported by other authors in the literature. 
But the difference was that most of our patients 
were admitted in advanced stage of the disease. 
Because of lack of an Oncology Department, 
absence of appropriate drugs for chemotherapy, 
and lack of radiotherapy and palliative 
Medicine,  our patients’ management and 
outcome were poor. There is an urgent need to 
improve our Hospital in establishing proper 
structure and facilities to attend to cancer 
patients efficiently.  
Recommendations 
• We appeal to the Ministry of Health to 
establish an oncology department in 
Rwanda and to ensure that chemotherapy, 
radiotherapy, palliative medicine and 
counseling sevices for patients affected with 
cancer are available. 
• A national cancer register should be opened. 
• Personnel should be trained to form 
multidisciplinary teams and specialists for 
the care of cancer patients. 
• Diagnostic facilities for cancer should 
be improved to make diagnosis of 
cancer quick and accurate.                                           
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